Condition
Malignant Mesothelioma|Metastatic Cancer
Estimated Enrollment: 196
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: P00804|PAPWORTH-MESOVATS|PAPWORTH-P00804|EU-20901|ISRCTN34321019
Study First Received: January 13, 2009
Last Updated: June 27, 2013
Estimated Primary Completion Date: February 2013
Primary Outcome Measures:
Survival at 1 year after treatment|Control of pleural effusion|Complications, including need for more surgery, persistent air leak requiring pleural intubation for > 10 days, and hospital stay for > 12 days|Symptoms and quality of life as assessed by the EuroQol questionnaire|Length of hospital stay|Exercise tolerance|Cost to the health service, in terms of resources used for procedures, hospital bed usage, and cost of primary and secondary care over 12 months
Sponsors and Collaborators:
Papworth Hospital NHS Foundation Trust
Website Link: https://ClinicalTrials.gov/show/NCT00821860
